[ET Net News Agency, 27 January 2022] INNOVENT BIO (01801) fell 10.27% to HK$33.2.
It hits an intra-day low of HK$33.2, hitting a 52-week low, and an intra-day high of
HK$35.9. The total shares traded was 3.93 million, with a value of HK$134.23m. FUTU SEC
INT'L accounts for greatest net responsive buying turnover of HK$6.79m, with volume
weighted average price of HK$34.103. CREDIT SUISSE (HK) SEC accounts for greatest net
responsive selling turnover of HK$11.5m, with volume weighted average price of HK$34.104.
The stock has fallen a combined 22.79% over the past 5 consecutive trading days.
The Hang Seng Index now fell 557 points, or 2.29% to 23,732; the Hang Seng China
Enterprises Index now fell 226 points, or 2.66% to 8,285; the Hang Seng TECH Index now
fell 212 points, or 3.8% to 5,384; with an overall turnover of HK$44.2b.
The SSE Composite Index now fell 40 points, or 1.16% to 3,415, with an overall turnover
of RMB147.2b.
The SZSE Component Index now fell 235 points, or 1.71% to 13,545, with an overall
turnover of RMB94.47b.

Basic Information
=================

----------------------------------
Nominal 33.200 % Chg -10.27%
High 35.900 Low 33.200
Shares Tr 3.93m Turnover 134.23m
10-D SMA 40.515 %H.V 75.662
20-D SMA 41.698 VWAP 34.184
50-D SMA 54.443 RSI14 25.876
----------------------------------
Status: Hitting a 52-week low, falling a combined 22.79% over the past 5 consecutive
trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
INNOVENT BIO (01801) 33.20 -10.27
HUTCHMED (00013) 43.30 -3.24
GENSCRIPT BIO (01548) 24.20 -6.92
ASCLETIS-B (01672) 3.73 -3.87
JUNSHI BIO (01877) 45.00 -5.76
JXR (01951) 7.36 -7.30
WUXI BIO (02269) 76.85 -3.58
TIGERMED (03347) 81.90 -4.43
CANSINOBIO-B (06185) 127.60 -5.06
REMEGEN-B (09995) 49.45 -4.07
---------------------------------------------
(ed)